Conditions:   Fractures, Bone;   Type II Diabetes
Interventions:   Drug: TZD only (RSG or PIO or troglitazone);   Drug: TZD + spironolactone;   Drug: TZD + amiloride
Sponsor:   GlaxoSmithKline
Completed - verified June 2011

Conditions:   Atherosclerosis;   Diabetes Mellitus
Intervention:   Drug: troglitazone
Sponsor:   Parke-Davis
Completed - verified June 2005

Condition:   Diabetes Mellitus
Intervention:  
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Aging (NIA);   The Office of Research on Minority Health and Health Disparities;   Office of Women's Health;   Indian Health Service;   Centers for Disease Control and Prevention;   General Clinical Research Program;   National Center for Research Resources (NCRR);   American Diabetes Association
Active, not recruiting - verified February 2011

Condition:   Sarcoma
Intervention:   Drug: troglitazone
Sponsors:   Dana-Farber Cancer Institute;   National Cancer Institute (NCI)
Active, not recruiting - verified June 2000